Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Condition: Pulmonary Disease Due to Mycobacteria (Diagnosis) Interventions: Drug: Amikacin; Drug: Tigecycline; Drug: Imipenem; Drug: Cefoxitin; Drug: Azithromycin; Drug: Clarithromycin; Drug: Clofazimine; Drug: Ethambutol; Drug: Linezolid; Drug: co-trimoxazole; Drug: Doxycycline; Drug: Moxifloxacin; Drug: Bedaquiline; Drug: Rifabutin Sponsors: The University of Queensland; Australian Government Department of Health; Children's Hospital Foundation; Cystic Fibrosis Foundation; Newcastle University; Griffith University; Erasmus Medical Center; Monash University; University of Copenhagen; Hôpi tal Cochin; South Australian Health and Medical Research Institute; University of Melbourne; James Cook University, Queensland, Australia; Murdoch Childrens Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Australia Health | Avelox | Azithromycin | Bedaquiline | Biaxin | Children | Clarithromycin | Doxycycline | Linezolid | Moxifloxacin | Research | Zithromax | Zyvox